Literature DB >> 18172185

Home blood-pressure monitoring in patients receiving sunitinib.

Michel Azizi, Antoine Chedid, Stéphane Oudard.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18172185     DOI: 10.1056/NEJMc072330

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  42 in total

Review 1.  Management of sunitinib-related adverse events: an evidence- and expert-based consensus approach.

Authors:  Viktor Grünwald; Daniel Kalanovic; Axel S Merseburger
Journal:  World J Urol       Date:  2010-05-11       Impact factor: 4.226

Review 2.  Sunitinib, hypertension, and heart failure: a model for kinase inhibitor-mediated cardiotoxicity.

Authors:  Rajesh Gupta; Michael L Maitland
Journal:  Curr Hypertens Rep       Date:  2011-12       Impact factor: 5.369

3.  NCCN Task Force report: update on the management of patients with gastrointestinal stromal tumors.

Authors:  George D Demetri; Margaret von Mehren; Cristina R Antonescu; Ronald P DeMatteo; Kristen N Ganjoo; Robert G Maki; Peter W T Pisters; Chandrajit P Raut; Richard F Riedel; Scott Schuetze; Hema M Sundar; Jonathan C Trent; Jeffrey D Wayne
Journal:  J Natl Compr Canc Netw       Date:  2010-04       Impact factor: 11.908

Review 4.  Recent Advances in Hypertension and Cardiovascular Toxicities With Vascular Endothelial Growth Factor Inhibition.

Authors:  Rhian M Touyz; Ninian N Lang; Joerg Herrmann; Anton H van den Meiracker; A H Jan Danser
Journal:  Hypertension       Date:  2017-06-19       Impact factor: 10.190

Review 5.  Targeted therapies in renal cell cancer: recent developments in imaging.

Authors:  Astrid A M van der Veldt; Martijn R Meijerink; Alfons J M van den Eertwegh; Epie Boven
Journal:  Target Oncol       Date:  2010-07-14       Impact factor: 4.493

6.  More sound cancer therapy biomarker development with active noise control.

Authors:  Michael L Maitland
Journal:  Oncologist       Date:  2013-03-13

7.  Acute aortic dissection with sporadic aortic calcifications during chemotherapy with sunitinib.

Authors:  Toru Adachi; Akira Sato; Daisuke Hanaoka; Kazutaka Aonuma
Journal:  J Vasc Surg Cases Innov Tech       Date:  2018-04-27

Review 8.  Noncardiac vascular toxicities of vascular endothelial growth factor inhibitors in advanced cancer: a review.

Authors:  Dorothy Keefe; Joanne Bowen; Rachel Gibson; Thean Tan; Meena Okera; Andrea Stringer
Journal:  Oncologist       Date:  2011-03-25

9.  Ambulatory monitoring detects sorafenib-induced blood pressure elevations on the first day of treatment.

Authors:  Michael L Maitland; Kristen E Kasza; Theodore Karrison; Kristin Moshier; Laura Sit; Henry R Black; Samir D Undevia; Walter M Stadler; William J Elliott; Mark J Ratain
Journal:  Clin Cancer Res       Date:  2009-09-22       Impact factor: 12.531

10.  Initial assessment, surveillance, and management of blood pressure in patients receiving vascular endothelial growth factor signaling pathway inhibitors.

Authors:  Michael L Maitland; George L Bakris; Henry R Black; Helen X Chen; Jean-Bernard Durand; William J Elliott; S Percy Ivy; Carl V Leier; Joann Lindenfeld; Glenn Liu; Scot C Remick; Richard Steingart; W H Wilson Tang
Journal:  J Natl Cancer Inst       Date:  2010-03-29       Impact factor: 13.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.